Cargando…
Mutation of PTPN11 (Encoding SHP-2) Promotes MEK Activation and Malignant Progression in Neurofibromin-Deficient Cells in a Manner Sensitive to BRAP Mutation
SIMPLE SUMMARY: Germline mutations of NF1 cause neurofibromatosis type 1 (NF1), which is characterized by multiple benign peripheral nerve sheath tumors known as neurofibromas. In some individuals with NF1, plexiform neurofibromas can give rise to malignant peripheral nerve sheath tumors. Here, we a...
Autores principales: | Harigai, Ritsuko, Sato, Ryo, Hirose, Chikako, Takenouchi, Toshiki, Kosaki, Kenjiro, Hirose, Takanori, Saya, Hideyuki, Arima, Yoshimi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9140047/ https://www.ncbi.nlm.nih.gov/pubmed/35625983 http://dx.doi.org/10.3390/cancers14102377 |
Ejemplares similares
-
Tranilast inhibits the expression of genes related to epithelial-mesenchymal transition and angiogenesis in neurofibromin-deficient cells
por: Harigai, Ritsuko, et al.
Publicado: (2018) -
De novo NSF mutations cause early infantile epileptic encephalopathy
por: Suzuki, Hisato, et al.
Publicado: (2019) -
Novel ARX mutation identified in infantile spasm syndrome patient
por: Takeshita, Yohei, et al.
Publicado: (2020) -
Protein Tyrosine Phosphatase SHP-2 (PTPN11) in Hematopoiesis and Leukemogenesis
por: Liu, Xia, et al.
Publicado: (2011) -
Loss of Ptpn11 (Shp2) drives satellite cells into quiescence
por: Griger, Joscha, et al.
Publicado: (2017)